From Algorithms to Outcomes: AI’s Role in Shaping Modern Medicine
Join for an engaging panel discussion on "From Algorithms to Outcomes: AI’s Role in Shaping Modern Medicine", co-hosted by Carnegie Mellon University (CMU), Pittsburgh Life Sciences Alliance (PLSA), and University of Pittsburgh.
This session brings together leading experts from academia, healthcare, and technology to explore the transformative potential of AI in medicine, from personalized treatments to operational efficiency.
Panelists:
Megan Shaw, CEO Pittsburgh Life Sciences Alliance (Moderator)
James Leslie, CFO Formation Bio
Julia Chou, COO Abridge AI
Neil Batlivala, CEO Pair Team
Richard Blaylock, Partner Pillsbury Law
Rob Lin, CEO Avista Therapeutics
Following the panel, connect with peers and industry leaders at an open mixer. Enjoy lively conversations, networking opportunities, and refreshments as we envision the next frontier of healthcare innovation.
📅 Date: January 15, 2025, 6 - 8:30 pm PT
📍 Location: San Francisco, 94111
Thank you to our sponsor Pillsbury Law Firm. Pillsbury is a forward-thinking law firm thriving in an environment of intense competition and change. Entrenched in elite markets, we do cutting-edge work for market leaders, innovators and disruptors throughout the U.S. and globally. Ranked among the Top 6 most active law firms for venture capital financings in the world, Pillsbury’s Emerging Companies & Venture Capital team helps entrepreneurs, emerging companies and investors drive the innovation that changes our world. The firm’s lawyers take shoestring startups to market-leading positions, serving clients as trusted advisors every step of the way. Whether advising entrepreneurs working out of a garage or the world’s largest public and private companies, we deliver exemplary client service and results, with highly regarded lawyers and business professionals operating across a diversity of leading practices.
Pittsburgh Life Sciences Alliance (PLSA) connects Southwest Pennsylvania's world class clinical, research, manufacturing, and technology strengths to drive human health innovation and economic growth.
Formation Bio is an AI-native pharma company changing the way drug development is done.
Abridge is an AI company that structures and summarizes medical conversations to unburden clinicians from clerical work, and focus on what matters most—their patients. Abridge’s science-centered technology platform transforms conversations into structured data and clinical documentation across over 50 specialties, 28+ languages, and several care settings. Abridge’s documentation solution is now saving clinicians 3 hours a day, and its EMR integrated patient-facing summaries are helping people better understand and follow through on their care plans.
Pair Team is an AI-enabled medical group focused on Medicaid and underserved communities.
Pillsbury Winthrop Shaw Pittman is an international law firm with a particular focus on the technology & life sciences, energy, financial, and real estate.
Avista Therapeutics is a biotechnology company developing next generation gene therapy for blindness.
Don't miss this opportunity to learn, collaborate, and shape the future of medicine!